Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 43975-252-05) b) 14-count bottle ...

FDA Drug Recall #D-0516-2019 — Class III — February 19, 2019

Recall Summary

Recall Number D-0516-2019
Classification Class III — Low risk
Date Initiated February 19, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Amerigen Pharmaceuticals Inc.
Location Lyndhurst, NJ
Product Type Drugs
Quantity a) 2,413 bottles b) 3,355 bottles

Product Description

Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 43975-252-05) b) 14-count bottle (NDC 43975-252-14), Rx only, Mfd. by: Stason Pharmaceuticals, Inc., Irvine, CA 92618, Dist. By: Amerigen Pharmaceuticals, Lyndhurst, NJ 07071

Reason for Recall

Failed dissolution specifications

Distribution Pattern

Product was distributed to 4 wholesalers/distributors and 1 retail account who may have further distribute the product throughout the United States.

Lot / Code Information

Lot #: a) 18J043A, Exp 09/30/2020, b) 18J043B, Exp 09/30/2020

Other Recalls from Amerigen Pharmaceuticals Inc.

Recall # Classification Product Date
D-0345-2019 Class III Temozolomide Capsules, 180 mg, packaged in a 14... Dec 20, 2018
D-0344-2019 Class III Temozolomide Capsules, 20 mg, packaged in a a) ... Dec 20, 2018
D-0249-2019 Class III Temozolomide capsules, 20 mg, packaged in a) 5-... Oct 5, 2018

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.